Pacenti Monia, Barzon Luisa, Favaretto Francesca, Fincati Karina, Romano Sara, Milan Gabriella, Vettor Roberto, Palù Giorgio
Department of Histology, Microbiology and Medical Biotechnologies, University of Padua, Via A. Gabelli 63, I-35121 Padua, Italy.
AIDS. 2006 Aug 22;20(13):1691-705. doi: 10.1097/01.aids.0000242815.80462.5a.
To elucidate the pathogenesis of HAART-associated lipodystrophy, by investigating the effects of antiretroviral drugs on adipocyte differentiation and gene expression profile.
Analysis of gene expression profile by DNA microarrays and quantitative RT-PCR of 3T3-L1 preadipocytes treated with the nucleoside reverse transcriptase inhibitors (NRTI) lamivudine, zidovudine, stavudine, and zalcitabine, and with the protease inhibitors (PI) indinavir, saquinavir, and lopinavir during maturation into adipocytes.
Under standard adipogenic differentiation protocols, PI significantly inhibited adipocyte differentiation, as demonstrated by cell viability assay and Oil Red O staining and quantification, whereas NRTI had mild effects on adipogenesis. Gene expression profile analysis showed that treatment with NRTI modulated the expression of transcription factors, such as Aebp1, Pou5f1 and Phf6, which could play a key role in the determination of the adipocyte phenotype. PI also modulated gene expression toward inhibition of adipocyte differentiation, with up-regulation of the Wnt signaling gene Wnt10a and down-regulation of the expression of genes encoding master adipogenic transcription factors (e.g., C/EBPalpha and PPARgamma), oestrogen receptor beta, and adipocyte-specific markers (e.g., Adiponectin, Leptin, Mrap, Cd36, S100A8).
This study identifies new genes modulated by PI and NRTI in differentiating adipocytes. Abnormal expression of these genes, which include master adipogenic transcription factors and genes involved in lipid metabolism and cell cycle control, could contribute to the understanding of the pathogenesis of HAART-associated lipodystrophy.
通过研究抗逆转录病毒药物对脂肪细胞分化及基因表达谱的影响,阐明高效抗逆转录病毒治疗(HAART)相关脂肪代谢障碍的发病机制。
采用DNA微阵列分析基因表达谱,并对在分化为脂肪细胞过程中用核苷类逆转录酶抑制剂(NRTI)拉米夫定、齐多夫定、司他夫定和扎西他滨,以及蛋白酶抑制剂(PI)茚地那韦、沙奎那韦和洛匹那韦处理的3T3-L1前脂肪细胞进行定量逆转录聚合酶链反应。
在标准的脂肪生成分化方案下,通过细胞活力测定、油红O染色及定量分析表明,PI显著抑制脂肪细胞分化,而NRTI对脂肪生成的影响较小。基因表达谱分析显示,NRTI处理可调节转录因子如Aebp1、Pou5f1和Phf6的表达,这些转录因子可能在脂肪细胞表型的决定中起关键作用。PI也调节基因表达以抑制脂肪细胞分化,使Wnt信号基因Wnt10a上调,而编码主要脂肪生成转录因子(如C/EBPα和PPARγ)、雌激素受体β及脂肪细胞特异性标志物(如脂联素、瘦素、Mrap、Cd36、S100A8)的基因表达下调。
本研究鉴定了PI和NRTI在分化脂肪细胞中调节的新基因。这些基因包括主要脂肪生成转录因子以及参与脂质代谢和细胞周期调控的基因,其异常表达可能有助于理解HAART相关脂肪代谢障碍的发病机制。